证券记录 · 已归档季度
ERAS
Erasca, Inc. · Healthcare · Biotechnology
12被追踪持有人
-3Δ持有人
45.80M持有股份
$58.17M报告持仓市值
+0新建仓位
−3清仓
动量输入（同类管理人）：
持有人广度 -20.0% ·
股份流向 +0.9% ·
净新建仓位 -20.0%
— 公式
集中积累 — 持股数量上升但持有人减少
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q2 2025
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q2 2026 | 97 | +13 | 109.93M | $2.01B | +17 | −4 |
| Q1 2026 | 87 | +18 | 99.27M | $1.57B | +25 | −7 |
| Q4 2025 | 69 | +1 | 63.96M | $237.91M | +1 | — |
| Q3 2025 | 16 | +1 | 49.01M | $106.84M | +1 | — |
| Q2 2025 | 12 | -3 | 45.80M | $58.17M | — | −3 |
| Q1 2025 | 12 | 0 | 17.13M | $23.47M | +1 | −1 |
| Q4 2024 | 12 | 0 | 25.73M | $64.58M | +1 | −1 |
| Q3 2024 | 11 | 0 | 18.60M | $50.78M | — | — |
| Q2 2024 | 11 | — | 15.91M | $37.56M | — | — |
持有人 · Q2 2025
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (被动) | 15.17M | — | $19.26M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | BlackRock ✦ (被动) | 15.17M | — | $19.26M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | BlackRock ✦ (被动) | 15.17M | — | $19.26M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | BlackRock ✦ (被动) | 15.17M | — | $19.26M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | BlackRock ✦ (被动) | 15.17M | — | $19.26M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | BlackRock ✦ (被动) | 15.17M | — | $19.26M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | BlackRock ✦ (被动) | 15.17M | — | $19.26M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | BlackRock ✦ (被动) | 15.17M | — | $19.26M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | BlackRock ✦ (被动) | 15.17M | — | $19.26M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | The Vanguard Group ✦ (被动) | 12.70M | — | $16.12M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | The Vanguard Group ✦ (被动) | 12.70M | — | $16.12M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | The Vanguard Group ✦ (被动) | 12.70M | — | $16.12M | 0.0% | n/c | 1 | SEC ↗ |
| 13 | Geode Capital Management ✦ (被动) | 4.84M | +1.6% | $6.14M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 14 | Geode Capital Management ✦ (被动) | 4.84M | +1.6% | $6.14M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 15 | State Street Global Advisors ✦ (被动) | 4.00M | -4.2% | $5.08M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 16 | Millennium Management ✦ | 3.80M | +17.8% | $4.82M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 17 | Marshall Wace ✦ | 2.07M | +2.3% | $2.63M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 18 | Marshall Wace ✦ | 2.07M | +2.3% | $2.63M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 19 | Wellington Management ✦ | 885.65K | +4.2% | $1.12M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 20 | Wellington Management ✦ | 885.65K | +4.2% | $1.12M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 21 | Wellington Management ✦ | 885.65K | +4.2% | $1.12M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 22 | Renaissance Technologies ✦ | 742.50K | -22.4% | $942,975 | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 23 | AQR Capital Management ✦ | 708.06K | +78.7% | $899,236 | 0.0% | ▲ Add | 5 | SEC ↗ |
| 24 | AQR Capital Management ✦ | 708.06K | +78.7% | $899,236 | 0.0% | ▲ Add | 5 | SEC ↗ |
| 25 | AQR Capital Management ✦ | 708.06K | +78.7% | $899,236 | 0.0% | ▲ Add | 5 | SEC ↗ |
| 26 | AQR Capital Management ✦ | 708.06K | +78.7% | $899,236 | 0.0% | ▲ Add | 5 | SEC ↗ |
| 27 | Two Sigma Investments ✦ | 427.60K | -27.7% | $543,056 | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 28 | Fidelity (FMR) ✦ | 376.98K | — | $478,760 | 0.0% | n/c | 1 | SEC ↗ |
| 29 | Fidelity (FMR) ✦ | 376.98K | — | $478,760 | 0.0% | n/c | 1 | SEC ↗ |
| 30 | T. Rowe Price ✦ | 86.47K | +13.4% | $110,000 | 0.0% | ▲ Add | 5 | SEC ↗ |
"持仓权重"= 该持仓占该管理人已申报13F股权价值的比例——即信念度衡量指标。✦ = 精选管理人。
新增买入方
| 本季度无新增被追踪买入方。 |
已清仓
| Point72 Asset Management | $55,515 | 曾为 0.0% |
| D. E. Shaw & Co. | $43,058 | 曾为 0.0% |
| Citadel Advisors | $551 | 曾为 0.0% |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 223 持有人, 272.55M 股份, $4.00B 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
该证券的被追踪持有人最常同时持有的其他证券——基于共同持有计数，而非基本面关联。
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q2 2025 ·
方法论 ·
通过API获取此数据